Official websites use. Share sensitive information only on official, secure websites. AIM: To identify the characteristic clinical, laboratory and radiological findings and response to treatment in patients with fascioliasis.
Initial clinical, laboratory and radiological findings were recorded. All patients were followed until a complete response was achieved or for 6 mo after treatment discontinuation.
Of the 8 patients with biliary phase fascioliasis, 2 patients displayed features that overlapped with both hepatic and biliary phase. Abdominal pain and right upper abdominal tenderness were the most prominent signs and symptoms in all patients.
Multiple nodular lesions like micro-abscesses on abdominal computerized tomography were the main radiological findings in patients with hepatic phase. Small linear filling defects in the distal choledochus were the main endoscopic retrograde cholangiopancreatography ERCP findings in patients with biliary phase.
Patients with hepatic phase were treated with triclabendazole alone, and patients with biliary phase were treated with triclabendazole and had live Fasciola hepatica extracted from the bile ducts during ERCP. Fascioliasis is an infection caused by a trematode of the liver, Fasciola hepatica, that particularly affects sheep, goats and cattle.
